Stratos Wealth Partners, LTD. - PDL BIOPHARMA INC ownership

Back to all holdings Add to watchlist

PDL BIOPHARMA INC's ticker is PDLI and the CUSIP is 69329Y104. A total of 163 filers reported holding PDL BIOPHARMA INC in Q2 2018. The put-call ratio across all filers is 1.66 and the average weighting 0.0%.

Links
Filings
External links
Quarter-by-quarter ownership
Stratos Wealth Partners, LTD. ownership history of PDL BIOPHARMA INC
ValueSharesWeighting
Q3 2018$6,000
-14.3%
2,3000.0%0.00%–
Q1 2018$7,000
+16.7%
2,3000.0%0.00%–
Q4 2017$6,000–2,300–0.00%–
 Download
Other shareholders
PDL BIOPHARMA INC shareholders Q2 2018
NameSharesValueWeighting ↓
Argent Trust Co 41,405$102,2700.01%
Diversified Trust Co 11,029$26,4690.00%
HANCOCK WHITNEY CORP 128,396$00.00%
RHUMBLINE ADVISERS 612$1,5110.00%
Ancora Advisors LLC 4,948$00.00%
Westside Investment Management, Inc. 500$00.00%
View complete list of PDL BIOPHARMA INC shareholders